Granules Pharmaceuticals Inc. recalls Colchicine Capsules 0.6 mg
- Published
- 15 Jan 2025
- Units affected
- 96 Bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03
- Brand / company
- Granules Pharmaceuticals Inc.
- Codes / lots
- Lot#: GPC240763B, Exp. Date 6/17/2026
- Distribution
- Nationwide within the United States
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 15 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.